We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OKLO
776
Oklo
OKLO
$6.86B
$245K 0.03%
+30,344
New +$229K
DIS icon
777
Walt Disney
DIS
$171B
$245K 0.03%
2,550
-5,066
-67% -$466K
OBDC icon
778
Blue Owl Capital
OBDC
$5.46B
$245K 0.03%
16,785
-6,450
-28% -$96.9K
UPST icon
779
Upstart Holdings
UPST
$2.63B
$244K 0.03%
+6,098
New +$203K
POR icon
780
Portland General Electric
POR
$5.94B
$244K 0.03%
+5,092
New +$238K
GIB icon
781
CGI
GIB
$14.9B
$243K 0.03%
+2,113
New +$231K
TFX icon
782
Teleflex
TFX
$5.9B
$243K 0.03%
981
-9,002
-90% -$2.1M
EPAC icon
783
Enerpac Tool Group
EPAC
$1.88B
$243K 0.03%
5,789
-2,882
-33% -$116K
BMBL icon
784
Bumble
BMBL
$394M
$242K 0.03%
37,913
+27,796
+275% +$209K
CABO icon
785
Cable One
CABO
$244M
$241K 0.03%
+688
New +$246K
RXRX icon
786
Recursion Pharmaceuticals
RXRX
$1.6B
$239K 0.03%
+36,244
New +$260K
XPOF icon
787
Xponential Fitness
XPOF
$281M
$238K 0.03%
19,228
-7,761
-29% -$114K
NRC icon
788
NRC Health Common Stock
NRC
$510M
$237K 0.03%
10,364
+660
+7% +$14.9K
MHK icon
789
Mohawk Industries
MHK
$7.09B
$235K 0.03%
+1,461
New +$210K
RARE icon
790
Ultragenyx Pharmaceutical
RARE
$2.55B
$234K 0.03%
+4,221
New +$215K
HTZ icon
791
Hertz
HTZ
$568M
$234K 0.03%
70,868
+6,658
+10% +$23.3K
GTES icon
792
Gates Industrial Corporation Ltd.
GTES
$6.69B
$234K 0.03%
+13,313
New +$227K
CFR icon
793
Cullen/Frost Bankers
CFR
$10.5B
$232K 0.03%
+2,072
New +$227K
LGF.A
794
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$230K 0.03%
29,423
+1,848
+7% +$15.5K
DBI icon
795
Designer Brands
DBI
$326M
$230K 0.03%
+31,155
New +$218K
LOPE icon
796
Grand Canyon Education
LOPE
$3.98B
$229K 0.03%
1,616
-3,279
-67% -$473K
AVGO icon
797
Broadcom
AVGO
$1.82T
$226K 0.03%
+1,308
New +$210K
APO icon
798
Apollo Global Management
APO
$71.3B
$223K 0.03%
1,783
-1,946
-52% -$225K
MCO icon
799
Moody's
MCO
$84B
$223K 0.03%
+469
New +$217K
BOC icon
800
Boston Omaha
BOC
$435M
$222K 0.03%
14,906
-19,684
-57% -$274K
30 31
32
33 34

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.